JP2712457B2 - Membrane separation device - Google Patents

Membrane separation device

Info

Publication number
JP2712457B2
JP2712457B2 JP33426088A JP33426088A JP2712457B2 JP 2712457 B2 JP2712457 B2 JP 2712457B2 JP 33426088 A JP33426088 A JP 33426088A JP 33426088 A JP33426088 A JP 33426088A JP 2712457 B2 JP2712457 B2 JP 2712457B2
Authority
JP
Japan
Prior art keywords
membrane
tank
membrane separation
water
circulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP33426088A
Other languages
Japanese (ja)
Other versions
JPH02180693A (en
Inventor
正明 宍戸
勇 加藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kurita Water Industries Ltd
Original Assignee
Kurita Water Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurita Water Industries Ltd filed Critical Kurita Water Industries Ltd
Priority to JP33426088A priority Critical patent/JP2712457B2/en
Publication of JPH02180693A publication Critical patent/JPH02180693A/en
Application granted granted Critical
Publication of JP2712457B2 publication Critical patent/JP2712457B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Separation Using Semi-Permeable Membranes (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は膜分離装置に係り、特に、循環ポンプによる
フロック破壊を抑制することにより、濾過水量を高める
と共に処理水質を向上させることが可能な膜分離装置に
関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a membrane separation device, and in particular, it is possible to increase the amount of filtered water and improve the quality of treated water by suppressing the destruction of flocs by a circulation pump. The present invention relates to a membrane separation device.

[従来の技術] 原水中に含有される微細な懸濁物質やコロイド物質、
溶解性物質等の分離成分を、凝集剤やpH調整剤を添加し
てフロック化し、懸濁物質として平行流方式で膜分離す
る場合、一般には第2図に示すような膜分離装置が採用
される。
[Prior art] Fine suspended or colloidal substances contained in raw water,
When a flocculant or a pH adjuster is added to separate components such as a soluble substance to form a floc, and a membrane is separated as a suspended substance by a parallel flow method, a membrane separation apparatus as shown in FIG. 2 is generally employed. You.

即ち、第2図の膜分離装置において、原水は、凝集槽
(又はpH調整槽)1にて凝集剤槽2からの凝集剤及び/
又はpH調整剤槽3からのpH調整剤が添加される。凝集処
理水は、循環槽4に送給され、循環ポンプPにて分離膜
5aを備える膜分離器5に平行流方式で導入され、懸濁物
質は分離、濃縮される。処理水は系外に排出される。な
お、第2図中、P1,P2は薬注ポンプである。
That is, in the membrane separation device shown in FIG. 2, raw water is supplied to the flocculating tank (or pH adjusting tank) 1 by the flocculant and / or
Alternatively, a pH adjuster from the pH adjuster tank 3 is added. The coagulated water is supplied to the circulation tank 4 and separated by the circulation pump P.
It is introduced into the membrane separator 5 provided with 5a in a parallel flow manner, and the suspended substance is separated and concentrated. The treated water is discharged out of the system. In FIG. 2, P 1 and P 2 are chemical injection pumps.

[発明が解決しようとする課題] 第2図に示す膜分離装置で膜分離処理を行なう場合に
おいて、膜分離器5の濾過流束(以下「フラックス」と
称す。)は、経時的に低下する。このフラックスの低下
の原因としては、 膜面への懸濁物質の蓄積による抵抗の上昇。
[Problems to be Solved by the Invention] When a membrane separation process is performed by the membrane separation apparatus shown in FIG. 2, the filtration flux (hereinafter, referred to as “flux”) of the membrane separator 5 decreases with time. . The cause of this decrease in flux is an increase in resistance due to accumulation of suspended solids on the membrane surface.

膜細孔内への懸濁物質の侵入による抵抗の上昇。Increased resistance due to penetration of suspended matter into the pores of the membrane.

循環ポンプPでの懸濁物質の微細化とそれに伴なう懸
濁物質の難濾過性化。
Refinement of the suspended solids by the circulating pump P and the accompanying difficulty in filtering the suspended solids.

が考えられる。本発明者らは更にフラックス低下の問題
について検討した結果、上記〜のうち、特にの要
因が大きく、循環ポンプによる懸濁物質の微細化によ
り、がより促進されること、また、循環ポンプにより
微細化されたものが膜を透過して処理水質も悪化するこ
とを見出した。
Can be considered. The present inventors further examined the problem of flux reduction, and found that among the above factors, the following factors were particularly large, and the fineness of the suspended substance by the circulation pump was further promoted. It has been found that the liquefied matter permeates through the membrane and the quality of the treated water deteriorates.

このような循環ポンプによる懸濁物質の微細化を軽減
するために、第3図に示す如く、循環槽4に直接凝集剤
及び/又はpH調整剤を添加して処理することも考えられ
る。(なお、第3図において、第2図に示すものと同一
の機能をなすものには同一符号を付し、その説明を省略
する。) しかしながら、第3図に示す膜分離装置では、凝集剤
及び/又はpH調整剤を添加後、膜分離に到るまでの時間
が短く、従って、凝集時間が短いことから、十分に凝集
が行なわれないうちに膜分離処理されることとなり、処
理水質の悪化及び懸濁物質による濾過抵抗の上昇の問題
がある。
In order to reduce the fineness of the suspended substance by such a circulating pump, as shown in FIG. 3, it is conceivable to add a flocculant and / or a pH adjuster directly to the circulation tank 4 for treatment. (Note that in FIG. 3, components having the same functions as those shown in FIG. 2 are denoted by the same reference numerals and description thereof is omitted.) However, in the membrane separation device shown in FIG. And / or the time until the membrane separation after the addition of the pH adjuster is short, and thus the coagulation time is short, so that the membrane separation treatment is performed before sufficient coagulation is performed, and the quality of the treated water quality is reduced. There are problems of deterioration and increased filtration resistance due to suspended matter.

本発明は上記従来の問題点を解決し、循環ポンプによ
るフロック破壊を抑制し、高い濾過水量にて、著しく優
れた水質の処理水を得ることができる膜分離装置を提供
することを目的とする。
An object of the present invention is to solve the above-mentioned conventional problems, to provide a membrane separation device capable of suppressing the destruction of flocs by a circulating pump, and obtaining a treated water of remarkably excellent water quality with a high amount of filtered water. .

[課題を解決するための手段] 本発明の膜分離装置は、原水に凝集剤及び/又はpH調
整剤を添加して凝集処理する凝集槽と、凝集処理水を平
行流方式で膜分離処理する膜分離器と、凝集処理水を膜
分離器に循環させる循環槽及び循環ポンプとを備える膜
分離装置において、該循環槽には凝集剤添加手段及び/
又はpH調整剤添加手段が設けられていることを特徴とす
る。
[Means for Solving the Problems] The membrane separation device of the present invention performs a membrane separation process of a coagulation tank by adding a coagulant and / or a pH adjuster to raw water and a coagulation treatment water in a parallel flow system. In a membrane separation apparatus including a membrane separator, a circulation tank for circulating coagulation-treated water through the membrane separator, and a circulation pump, the circulation tank includes a coagulant adding means and / or
Alternatively, a pH adjusting agent adding means is provided.

以下に図面を参照して本発明を詳細に説明する。第1
図は本発明の一実施例に係る膜分離装置の系統図であ
る。
Hereinafter, the present invention will be described in detail with reference to the drawings. First
FIG. 1 is a system diagram of a membrane separation device according to one embodiment of the present invention.

図示の膜分離装置は、凝集槽1、凝集剤槽2、pH調整
剤槽3、循環槽4、分離膜5aを備える膜分離器5、循環
ポンプPで主に構成され、これらが配管11〜17で接続さ
れている。P1,P2は薬注ポンプである。
The illustrated membrane separation apparatus mainly includes a coagulation tank 1, a coagulant tank 2, a pH adjuster tank 3, a circulation tank 4, a membrane separator 5 having a separation membrane 5a, and a circulation pump P. Connected at 17. P 1 and P 2 are chemical injection pumps.

第1図に示す膜分離装置により処理を行なう場合、原
水はまず配管11より凝集槽に導入され、凝集剤槽2より
薬注ポンプP1を備える配管16、16aを経て供給される凝
集剤及び/又はpH調整剤槽3より薬注ポンプP2を備える
配管17、17aを経て供給されるpH調整剤で凝集処理され
る。
When processing the membrane separation apparatus shown in FIG. 1, the raw water is introduced into flocculation tank from first piping 11, coagulant is supplied through a pipe 16,16a that from coagulant tank 2 comprises a chemical feeding, chemical dosing pump P 1 and / or coagulation treatment at pH adjusting agent supplied through a pipe 17,17a with a chemical feeding, chemical dosing pump P 2 than the pH adjusting agent tank 3.

凝集処理水は配管12、循環槽4、配管13を経て、循環
ポンプPにより膜分離器5に分離膜5aに対して平行流方
式で導入される。膜分離器5の濃縮水は、配管14を経て
循環槽4に循環され、一方、処理水は配管15を経て系外
に排出される。
The coagulated water passes through the pipe 12, the circulation tank 4, and the pipe 13, and is introduced into the membrane separator 5 by the circulation pump P in a parallel flow manner with respect to the separation membrane 5a. The concentrated water of the membrane separator 5 is circulated to the circulation tank 4 via a pipe 14, while the treated water is discharged out of the system via a pipe 15.

循環槽4においては、配管14より循環された濃縮水
(循環水)及び配管12を経て凝集槽1から導入された凝
集処理水に、凝集剤槽2より薬注ポンプP1を備える配管
16、16bを経て凝集剤及び/又はpH調整剤槽3より薬注
ポンプP2を備える配管17、17bを経てpH調整剤が添加さ
れる。添加された凝集剤及び/又はpH調整剤により、配
管14より循環された濃縮水中の懸濁物質、特に循環ポン
プPにより微細化された懸濁物質は、効果的に再凝集さ
れる。また、配管12を経て凝集槽1から導入された凝集
処理水は、更に凝集が促進される。
In the circulating tank 4, the concentrated water (circulated water) circulated from the pipe 14 and the coagulated treated water introduced from the coagulating tank 1 via the pipe 12 are connected to the pipe provided with the chemical injection pump P 1 from the coagulant tank 2.
Flocculants and / or pH adjusting agent through a piping 17,17b with a chemical feeding, chemical dosing pump P 2 than the pH adjusting agent tank 3 is added through 16, 16b. With the added flocculant and / or pH adjuster, the suspended matter in the concentrated water circulated through the pipe 14, particularly the suspended matter fined by the circulation pump P, is effectively reagglomerated. Further, the flocculation treatment water introduced from the flocculation tank 1 through the pipe 12 further promotes the flocculation.

このため、常に、微細化した懸濁物質が著しく低減さ
れた凝集処理水及び循環水が膜分離器5に供給されるよ
うになり、フラックスが高く維持され、また処理水質も
著しく高いものとなる。
For this reason, the flocculated water and the circulating water, in which the finely divided suspended substances are significantly reduced, are always supplied to the membrane separator 5, the flux is maintained at a high level, and the quality of the treated water is also extremely high. .

なお、本発明の膜分離装置により処理される原水とし
ては特に制限はないが、例えば、ゴミ焼却場洗煙廃水や
メッキ工場廃水等の金属含有廃水等が挙げられる。
The raw water to be treated by the membrane separation apparatus of the present invention is not particularly limited, and examples thereof include metal-containing wastewater such as garbage incineration smoke washing wastewater and plating factory wastewater.

また、膜分離器の分離膜としても特に制限はなく、通
常の平行流方式の膜分離処理に用いられる精密濾過膜や
限外濾過膜を用いることができる。特に、精密濾過膜を
用いた場合には、処理水質も安定かつ高水質となり、優
れた効果が得られる。
The separation membrane of the membrane separator is not particularly limited, and a microfiltration membrane or an ultrafiltration membrane used in a usual parallel flow type membrane separation treatment can be used. In particular, when a microfiltration membrane is used, the quality of the treated water is stable and high, and excellent effects can be obtained.

本発明において、循環槽への凝集剤及び/又はpH調整
剤の添加は連続的であっても間欠的であっても良く、原
水水質や循環水水質等に応じて適宜決定される。
In the present invention, the addition of the flocculant and / or the pH adjuster to the circulation tank may be continuous or intermittent, and is appropriately determined according to the raw water quality, the circulating water quality, and the like.

なお、本発明において、凝集槽と循環槽とに、凝集剤
及び/又はpH調整剤を2段添加するため、薬剤使用量が
増加することが危惧されるが、本発明においては、従来
と同程度の添加量を凝集槽と循環槽とに分割して添加す
れば良く、特に薬剤使用量を増加させる必要はない。
In the present invention, since the coagulant and / or the pH adjuster are added in two stages to the coagulation tank and the circulation tank, there is a concern that the amount of the drug used may increase, but in the present invention, the amount of the chemical used is about the same as the conventional one May be added separately to the coagulation tank and the circulation tank, and it is not necessary to particularly increase the amount of drug used.

[作用] 本発明の膜分離装置においては、循環槽に凝集剤及び
/又はpH調整剤添加手段が設けられているため、循環ポ
ンプによる微細化懸濁物質は、循環槽に返送された際
に、添加された凝集剤及び/又はpH調整剤により再凝集
される。
[Operation] In the membrane separation device of the present invention, since the flocculating agent and / or the pH adjusting agent adding means is provided in the circulation tank, the finely divided suspended substance by the circulation pump is returned to the circulation tank when returned. Is reagglomerated by the added flocculant and / or pH adjuster.

このため、微細化された懸濁物質が濾過性能を悪化さ
せたり、膜細孔内に侵入して膜抵抗を上昇させ、フラッ
クスを低下させ、更には膜を透過して処理水質を悪化さ
せるなどの問題が改善される。
For this reason, finely divided suspended substances deteriorate filtration performance, increase membrane resistance by penetrating into the pores of the membrane, reduce flux, and further deteriorate the quality of treated water by permeating the membrane. The problem is improved.

[実施例] 以下に実施例及び比較例を挙げて、本発明をより具体
的に説明する。
EXAMPLES Hereinafter, the present invention will be described more specifically with reference to Examples and Comparative Examples.

実施例1 第1図に示す本発明の膜分離装置により膜分離試験を
行なった。なお、原水、分離膜及び運転条件等は下記の
通りである。
Example 1 A membrane separation test was performed using the membrane separation apparatus of the present invention shown in FIG. In addition, raw water, a separation membrane, operating conditions, etc. are as follows.

原水:フッ素含有廃水 F;30mg/l 分離膜:チューブラー型精密濾過膜 孔径;0.2μm 凝集槽薬注量: 硫酸バンド;1500mg/l (NaOHで中和) 循環槽薬注量: 硫酸バンド;500mg/l(間欠流入) (NaOHで中和) 膜分離器運転条件: 圧力;2kg/cm2 循環水量;8.5l/min 逆洗;1回/30分 試験結果を第1表に示す。Raw water: Fluorine-containing wastewater F; 30 mg / l Separation membrane: Tubular type microfiltration membrane Pore size: 0.2 μm Coagulation tank medicine injection amount: Sulfuric acid band; 1500 mg / l (neutralized with NaOH) Circulation tank medicine injection amount: Sulfuric acid band; 500 mg / l (intermittent inflow) (neutralized with NaOH) Membrane separator operating conditions: pressure; 2 kg / cm 2 circulating water flow; 8.5 l / min backwash; once / 30 minutes The test results are shown in Table 1.

実施例2 循環槽の薬注を連続注入したこと以外は実施例1と同
様に試験を行ない、結果を第1表に示した。
Example 2 A test was performed in the same manner as in Example 1 except that the chemical injection in the circulation tank was continuously injected, and the results are shown in Table 1.

比較例1 第2図に示す膜分離装置により、凝集槽にのみ硫酸バ
ンドを2000mg/l添加し、NaOHで中和したこと以外は実施
例1と同様に試験を行ない、結果を第1表ニ示した。
Comparative Example 1 A test was conducted in the same manner as in Example 1 except that a sulfate band of 2000 mg / l was added only to the flocculation tank and neutralized with NaOH using the membrane separation apparatus shown in FIG. Indicated.

比較例2 第3図に示す膜分離装置により、凝集槽を設けず、原
水を直接循環槽に導入し、循環槽に硫酸バンド2000mg/l
を添加しNaOHで中和したこと以外は実施例1と同様にし
て試験を行ない、結果を第1表に示した。
Comparative Example 2 Raw water was directly introduced into the circulation tank by using the membrane separation apparatus shown in FIG.
Was performed in the same manner as in Example 1 except that the solution was added and neutralized with NaOH. The results are shown in Table 1.

第1表より次のことが明らかである。 The following is clear from Table 1.

実施例1、2の本発明の膜分離装置によれば、比較例
1の第2図の膜分離装置に比べて濾過水量は約40%増加
し、膜処理水質も安定して良好であった。これは、循環
ポンプにより微細化した懸濁物質が循環槽に間欠ないし
連続に添加された硫酸バンドにより再凝集されたためと
考える。比較例2の第3図の膜分離装置によれば、比較
例1の第2図の膜分離装置に比べて、濾過水量は15%増
加し、膜処理水質も良好であったが、実施例1、2に比
べると効果は小さかった。これは比較例2の第3図の膜
分離装置は、循環槽で凝集反応と再凝集を同時に行なう
ものであるが、凝集の反応時間が本法に比べて短いこと
から、凝集が完全に行なえないため、微小懸濁物質が透
過して処理水に影響したためと考えられる。また、凝集
が完全でないため懸濁物質の濾過抵抗が上昇し、実施例
1、2に比べてフラックスも低下したためと考えられ
る。
According to the membrane separation devices of the present invention of Examples 1 and 2, the amount of filtered water was increased by about 40% and the quality of the treated water was stably good as compared with the membrane separation device of FIG. 2 of Comparative Example 1. . This is considered to be because the suspended matter refined by the circulation pump was reaggregated by the sulfuric acid band intermittently or continuously added to the circulation tank. According to the membrane separator shown in FIG. 3 of Comparative Example 2, the amount of filtered water was increased by 15% and the quality of the membrane treated water was better than that of the membrane separator shown in FIG. 2 of Comparative Example 1. The effect was small compared to 1 and 2. The membrane separation apparatus shown in FIG. 3 of Comparative Example 2 performs the coagulation reaction and the re-coagulation simultaneously in the circulation tank. This is probably because the fine suspended solids permeated and affected the treated water. In addition, it is considered that the filtration resistance of the suspended substance was increased due to incomplete aggregation, and the flux was also reduced as compared with Examples 1 and 2.

実施例3 第1図に示す本発明の膜分離装置により膜分離試験を
行なった。なお、原水、分離膜及び運転条件等は下記の
通りである。
Example 3 A membrane separation test was performed using the membrane separation apparatus of the present invention shown in FIG. In addition, raw water, a separation membrane, operating conditions, etc. are as follows.

原水:メッキ工場廃水 pH;3.0 COD;20mg/l Cu;16.9mg/l Fe;1.1mg/l 分離膜:平板型限外濾過膜 分画分子量;50000 凝集槽薬注量: MgSO4・7H2O;70mg/l(Mgとして) (NaOHでpH11に調整) 循環槽薬注量: MgSO4・7H2O;30mg/l(Mgとして間欠注入) (NaOHでpH11に調整) 膜分離器運転条件: 圧力;2kg/cm2 循環水量;9.6l/min 試験結果を第2表に示す。Raw water: plating wastewater pH; 3.0 COD; 20mg / l Cu; 16.9mg / l Fe; 1.1mg / l separation membrane: flat ultrafiltration membrane a fractionation molecular weight; 50,000 flocculation tank chemical feed amount: MgSO 4 · 7H 2 O; 70mg / l (as Mg) (adjusted to at NaOH pH11) circulation tank chemical feed amount: MgSO 4 · 7H 2 O; ( intermittent infusion as Mg) 30mg / l (adjusted to pH11 with NaOH) membrane separator operating conditions : Pressure; 2 kg / cm 2 circulating water volume; 9.6 l / min The test results are shown in Table 2.

実施例4 循環槽の薬注を連続注入したこと以外は実施例3と同
様に試験を行ない、結果を第2表に示した。
Example 4 A test was conducted in the same manner as in Example 3 except that the chemical injection in the circulation tank was continuously injected, and the results are shown in Table 2.

比較例3 第2図に示す膜分離装置により、凝集槽にのみMgSO4
・7H2Oを100mg/l(Mgとして)添加し、NaOHでpH11に調
整したこと以外は実施例3と同様に試験を行ない、結果
を第2表に示した。
The membrane separation apparatus shown in Comparative Example 3 Fig. 2, MgSO 4 only coagulation tank
A test was conducted in the same manner as in Example 3 except that 100 mg / l (as Mg) of 7H 2 O was added and the pH was adjusted to 11 with NaOH, and the results are shown in Table 2.

比較例4 第3図に示す膜分離装置により、凝集槽を設けず、原
水を直接循環槽に導入し、循環槽にMgSO4・7H2Oを100mg
/l(Mgとして)添加しNaOHでpH11に調整したこと以外は
実施例3と同様にして試験を行ない、結果を第2表に示
した。
Comparative Example 4 Raw water was directly introduced into the circulation tank by using the membrane separation apparatus shown in FIG. 3 without providing a flocculation tank, and 100 mg of MgSO 4 .7H 2 O was introduced into the circulation tank.
The test was performed in the same manner as in Example 3 except that the pH was adjusted to 11 with NaOH after adding / l (as Mg), and the results are shown in Table 2.

第2表より次のことが明らかである。 The following is clear from Table 2.

実施例3、4の本発明の膜分離装置によれば、比較例
3の第2図の膜分離装置に比べて濾過水量は約20%増加
した。なお、実施例3、4と比較例3、4とでは、処理
水質は同等であった。これは分画分子量50000の限外濾
過膜を用いているため、循環ポンプにより微細化した懸
濁物質でも除去可能であったことによると考えられる。
According to the membrane separation devices of the present invention of Examples 3 and 4, the amount of filtered water was increased by about 20% as compared with the membrane separation device of Comparative Example 3 shown in FIG. Note that the treated water quality was the same in Examples 3 and 4 and Comparative Examples 3 and 4. This is presumably because the use of an ultrafiltration membrane having a molecular weight cut-off of 50,000 enabled the removal of fine suspended substances using a circulating pump.

つまり、限外濾過膜の場合は、細孔径が精密濾過膜よ
り小さいので微細化されても膜を透過しないため、処理
水質には影響しないものと考えられる。
That is, in the case of the ultrafiltration membrane, the pore size is smaller than the microfiltration membrane, so that the microfiltration does not permeate the membrane even if it is miniaturized.

実施例5 第1図に示す本発明の膜分離装置により膜分離試験を
行なった。なお、原水、分離膜及び運転条件等は下記の
通りである。
Example 5 A membrane separation test was performed using the membrane separation apparatus of the present invention shown in FIG. In addition, raw water, a separation membrane, operating conditions, etc. are as follows.

原水:鉛、水銀含有廃水 Pb;0.5mg/l Hg;0.2mg/l 分離膜:チューブラー型精密濾過膜 孔径;0.2μm 凝集槽薬注量: FeCl3・6H2O;80mg/l(Feとして) (NaOHで中和) 循環槽薬注量: FeCl3・6H2O;20mg/l(Feとして間欠注入) (NaOHで中和) 膜分離器運転条件: 圧力;2kg/cm2 循環水量;8.5l/min 逆洗;1回/30分 試験結果を第3表に示す。Raw water: lead, mercury-containing waste water Pb; 0.5mg / l Hg; 0.2mg / l separation membrane: tubular type microfiltration membrane pore size; 0.2 [mu] m flocculation tank chemical feed amount: FeCl 3 · 6H 2 O; 80mg / l (Fe as) (neutralized with NaOH) circulation tank chemical feed amount: FeCl 3 · 6H 2 O; 20mg / l ( intermittent infusion as Fe) (neutralized with NaOH) membrane separator operating conditions: pressure; 2 kg / cm 2 circulating water ; 8.5 l / min Backwash; 1 time / 30 minutes The test results are shown in Table 3.

実施例6 循環槽の薬注を連続注入したこと以外は実施例5と同
様に試験を行ない、結果を第3表に示した。
Example 6 A test was conducted in the same manner as in Example 5 except that the chemical injection in the circulation tank was continuously injected, and the results are shown in Table 3.

比較例5 第2図に示す膜分離装置により、凝集槽にのみFeCl3
・6H2Oを100mg/l(Feとして)添加し、NaOHで中和した
こと以外は実施例5と同様に試験を行ない、結果を第3
表に示した。
The membrane separation apparatus shown in Comparative Example 5 FIG. 2, FeCl 3 only coagulation tank
A test was performed in the same manner as in Example 5 except that 6H 2 O was added at 100 mg / l (as Fe) and neutralized with NaOH,
It is shown in the table.

比較例6 第3図に示す膜分離装置により、凝集槽を設けず、原
水を直接循環槽に導入し、循環槽にFeCl3・6H2Oを100mg
/l(Feとして)添加しNaOHで中和したこと以外は実施例
5と同様にして試験を行ない、結果を第3表に示した。
Comparative Example 6 Raw water was directly introduced into the circulation tank by using the membrane separation apparatus shown in FIG. 3 without providing a flocculation tank, and 100 mg of FeCl 3 .6H 2 O was introduced into the circulation tank.
The test was conducted in the same manner as in Example 5 except that / l (as Fe) was added and neutralized with NaOH, and the results are shown in Table 3.

第3表より、本発明の膜分離装置によれば、比較例5
の第2図の膜分離装置に比べ、濾過水量が約25%増加
し、膜処理水質も安定して良好であることが明らかであ
る。
According to Table 3, according to the membrane separation device of the present invention, Comparative Example 5
It is clear that the amount of filtered water is increased by about 25% and the quality of the treated water is stable and good as compared with the membrane separation device shown in FIG.

[発明の効果] 以上詳述した通り、本発明の膜分離装置によれば、循
環ポンプにより微細化した懸濁物質が、循環槽にて再凝
集されるため、 微細化に伴なう懸濁物質の難濾過性化、 膜細孔内への懸濁物質の侵入による抵抗の上昇、 が抑制され、フラックスの低下が抑制される。また、微
細化した懸濁物質の膜透過も防止され、処理水質も向上
する。
[Effects of the Invention] As described above in detail, according to the membrane separation device of the present invention, the suspended substance miniaturized by the circulation pump is reaggregated in the circulation tank, so that the suspended material accompanying the micronization is suspended. This makes it difficult to filter the substance, increases the resistance due to the penetration of suspended substances into the pores of the membrane, and suppresses the decrease in flux. In addition, the permeation of the finely divided suspended substance through the membrane is prevented, and the quality of the treated water is improved.

このため、本発明の膜分離装置によれば、極めて良好
な水質の処理水も従来に比べて20〜40%高いフラックス
にて、安定に得ることが可能とされる。
For this reason, according to the membrane separation device of the present invention, it is possible to stably obtain treated water having extremely good water quality with a flux 20 to 40% higher than that of the conventional method.

【図面の簡単な説明】[Brief description of the drawings]

第1図は本発明の一実施例に係る膜分離装置の系統図、
第2図及び第3図は各々従来の膜分離装置を示す系統図
である。 1……凝集槽、2……凝集剤槽、3……pH調整剤槽、4
……循環槽、5……膜分離器、P……循環ポンプ。
FIG. 1 is a system diagram of a membrane separation device according to one embodiment of the present invention,
2 and 3 are system diagrams each showing a conventional membrane separation device. 1 ... coagulation tank, 2 ... coagulant tank, 3 ... pH adjuster tank, 4
... circulation tank, 5 ... membrane separator, P ... circulation pump.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭62−61691(JP,A) 特開 昭61−125407(JP,A) 特開 昭56−31496(JP,A) 特開 昭55−97217(JP,A) 特開 昭52−125476(JP,A) 特開 昭52−73555(JP,A) ──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-62-61691 (JP, A) JP-A-61-125407 (JP, A) JP-A-56-31496 (JP, A) 97217 (JP, A) JP-A-52-125476 (JP, A) JP-A-52-73555 (JP, A)

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】原水に凝集剤及び/又はpH調整剤を添加し
て凝集処理する凝集槽と、凝集処理水を平行流方式で膜
分離処理する膜分離器と、凝集処理水を膜分離器に循環
させる循環槽及び循環ポンプとを備える膜分離装置にお
いて、該循環槽には凝集剤添加手段及び/又はpH調整剤
添加手段が設けられていることを特徴とする膜分離装
置。
1. A coagulation tank for coagulating a raw water by adding a coagulant and / or a pH adjuster, a membrane separator for separating the coagulated water in a parallel flow manner, and a membrane separator for the coagulated water. A membrane separation device comprising a circulation tank and a circulation pump for circulating water, wherein the circulation tank is provided with a flocculant adding means and / or a pH adjusting agent adding means.
JP33426088A 1988-12-28 1988-12-28 Membrane separation device Expired - Fee Related JP2712457B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP33426088A JP2712457B2 (en) 1988-12-28 1988-12-28 Membrane separation device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33426088A JP2712457B2 (en) 1988-12-28 1988-12-28 Membrane separation device

Publications (2)

Publication Number Publication Date
JPH02180693A JPH02180693A (en) 1990-07-13
JP2712457B2 true JP2712457B2 (en) 1998-02-10

Family

ID=18275351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP33426088A Expired - Fee Related JP2712457B2 (en) 1988-12-28 1988-12-28 Membrane separation device

Country Status (1)

Country Link
JP (1) JP2712457B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5224380B2 (en) * 2009-03-09 2013-07-03 株式会社高松メッキ Manufacturing method of low grade Ni recycled sludge

Also Published As

Publication number Publication date
JPH02180693A (en) 1990-07-13

Similar Documents

Publication Publication Date Title
AU2014235024B2 (en) Process for water treatment prior to reverse osmosis
CN106745981A (en) A kind of system and method for high-salt wastewater treatment for reuse
JP2012200652A (en) Biological treatment apparatus
JPS6359389A (en) Treatment of dyeing waste water
JP2712457B2 (en) Membrane separation device
WO2019208532A1 (en) Water treatment method and water treatment apparatus
JP4470584B2 (en) Water treatment method and water treatment apparatus
JP2003525727A (en) Membrane filtration method
Thiruvenkatachari et al. Flocculation—cross-flow microfiltration hybrid system for natural organic matter (NOM) removal using hematite as a flocculent
JP4466268B2 (en) Method and apparatus for recovering activated sludge treated water
JPH1199389A (en) Treatment of water containing organic component and manganese
JPH0576876A (en) Treatment of waste water containing fluorine and manganese
JPH10180008A (en) Membrane separation device
JP3111508B2 (en) Treatment method for wastewater containing heavy metals
JP2002346347A (en) Method and apparatus for filtration
JP2003334566A (en) Method and device for treating drain containing fluorine
JP2927702B2 (en) Wastewater treatment method
JP3079604B2 (en) Water treatment equipment
CN111051253A (en) Apparatus and method for treating silica-containing water
JP6515443B2 (en) Method and apparatus for biological treatment of organic substance-containing water containing heavy metals and / or hardness component
JP2019188338A (en) Water treatment method and water treatment apparatus
JPH0418994A (en) Treatment of organic waste water
JPH0295497A (en) Membrane separation process
JP2014046235A (en) Fresh water generating method
JP3172726B2 (en) Low pollution water treatment equipment

Legal Events

Date Code Title Description
FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 10

Free format text: PAYMENT UNTIL: 20071031

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081031

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees